| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Roth David is a Chief Medical Officer at Syros Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 12,099 | $0.20 | $2,382.29 | -100% | |
| Apr 3, 2024 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,451 | $4.95 | $51,732.45 | -100% | |
| Apr 2, 2024 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 150 | $4.98 | $747.05 | -1.4% | |
| Dec 12, 2023 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 6,287 | $4.95 | $31,120.65 | -100% | |
| Dec 6, 2023 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 6,287 | $3.95 | $24,833.65 | -50.0% | |
| Jul 31, 2023 | SYRS Syros Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 7,348 | $3.95 | $29,024.60 | -100% |